Sarcomeric hypertrophic cardiomyopathy (HCM) is a prevalent genetic disorder
characterised by left ventricular hypertrophy, myocardial disarray, and an increased risk of …

Patients with obstructive hypertrophic cardiomyopathy (oHCM) have increased risk of
arrhythmia, stroke, heart failure, and sudden death. Contemporary management of oHCM …

BACKGROUND One of the major determinants of exercise intolerance and limiting
symptoms among patients with obstructive hypertrophic cardiomyopathy (HCM) is an …

Arrhythmogenic cardiomyopathy (ACM) is a heart muscle disease characterized by
prominent “non-ischemic” myocardial scarring predisposing to ventricular electrical …

Cardiac magnetic resonance (CMR) imaging has witnessed substantial progress with the
advent of parametric mapping techniques, most notably T1 and T2 mapping. These …

Pediatric cardiomyopathies (CMs) and electrical diseases constitute a heterogeneous
spectrum of disorders distinguished by structural and electrical abnormalities in the heart …

Hypertrophic cardiomyopathy (HCM) is the commonest genetic cardiomyopathy world-wide,
affecting approximately 1 in 500 individuals. Current therapeutic interventions comprise …

Hypertrophic cardiomyopathy (HCM) is one of the most common genetic cardiovascular
diseases, and it shows an autosomal dominant pattern of inheritance. HCM can be clinically …

Aims To characterize the phenotype, clinical outcomes and rate of disease progression in
patients with early‐stage non‐ischaemic cardiomyopathy (early‐NICM). Methods and results …

Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease and the
leading cause of sudden cardiac death in young people. Mutations in genes that encode …